Serum biomarkers of vascular cognitive impairment evaluated by bead-based proteomic technology

Neuroscience Letters

Volumn 463, Issue 1, 2009, Pages 6-11

  Xi, Liu ^a   Junjian, Zhang ^a   Yumin, Liu ^a   Yunwen, Luo ^b   Hongbin, Wen ^c  

^a WUHAN UNIVERSITY   (China)

^b 1st Renmin Hospital   (China)

^c Zhongxin Hospital   (China)

Author keywords

Magnetic bead; MALDI TOF MS; Trace amine associated receptor 6; Vascular cognitive impairment

Indexed keywords

BIOLOGICAL MARKER; CELL RECEPTOR; TRACE AMINE ASSOCIATED RECEPTOR 6; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPUTER PROGRAM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DATABASE; PROTEIN PURIFICATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY;

AGED; BIOLOGICAL MARKERS; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEMENTIA; DEMENTIA, VASCULAR; HUMANS; MAGNETICS; MICROSPHERES; PEPTIDES; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 68149158268     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.056     Document Type: Article

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (1994), American Psychiatric Association, Washington, DC
2. Baumann S., Ceglarek U., Fiedler G.M., Lembcke J., Leichtle A., and Thiery J. Standardized approach to proteome profiling of human based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin. Chem. 51 (2005) 973-980
3. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., Durkin M.M., Lakhlani P.P., Bonini J.A., Pathirana S., Boyle N., Pu X., Kouranova E., Lichtblau H., Ochoa F.Y., Branchek T.A., and Gerald C. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. 98 (2001) 8966-8971
4. Bosso N., Chinello C., Picozzi S.C.M., Gianazza E., Mainini V., Galbusera C., Raimondo F., Perego R., Casellato S., Rocco F., Ferrero S., Bosari S., Mocarelli P., Kienle M.G., and Magni F. Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteomics Clin. Appl. 2 (2008) 1036-1046
5. Bowler J.V., and Hachinski V.C. Vascular Cognitive Impairment (2003), Oxford University Press, Oxford and New York
6. Burchett S.A., and Hicks T.P. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog. Neurobiol. 79 (2006) 223-246
7. Cheng A.J., Chen L.C., Chien K.Y., Chen Y.J., Chang J.T.C., Wang H.M., and Chen I.H. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin. Chem. 51 (2005) 2236-2244
8. D'Andrea G., Terrazzino S., Fortin D., Farruggio A., Rinaldi L., and Leon A. HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes. Neurosci. Lett. 346 (2003) 89-92
9. Diamandis E.P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell Proteomics 3 (2004) 367-378
10. Garrett K.D., Browndyke J.N., Whelihan W., Paul R.H., DiCarlo M., Moser D.J., Cohen R.A., and Ott B.R. The neuropsychological profile of vascular cognitive impairment-no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. Arch. Clin. Neuropsychol. 19 (2004) 745-757
11. Hachinski V., Iadecola C., Petersen R.C., Breteler M.M., Nyenhuis D.L., Black S.E., Powers W.J., DeCarli C., Merino J.G., Kalaria R.N., Vinters H.V., Holtzman D.M., Rosenberg G.A., Wallin A., Dichgans M., Marler J.R., and Leblanc G.G. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37 (2006) 2220-2241
12. Herzig M.C., Winkler D., Burgermeister P., Pfeifer M., Kohler E., Schmidt S.D., Danner S., Abramowski D., Sturchler-Pierrat C., Burki K., Duinen S.G., Maat-Schieman M.L., Staufenbiel M., Mathews P.M., and Jucker M. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 7 (2004) 954-960
13. Hortin G.L. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin. Chem. 52 (2006) 1223-1237
14. Ingles J.L., Wentzel C., Fisk J.D., and Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 33 (2002) 1999-2002
15. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J., Vavssiere C., Cruaud C., Cabanis E., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G., and Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 (1996) 707-710
16. Juby A., Tench S., and Baker V. The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score. Can. Med. Assoc. J. 167 (2002) 859-864
17. Lee K.S., Kim E.A., Hong C.H., Lee D.W., Oh B.H., and Cheong H.K. Clock drawing test in mild cognitive impairment: quantitative analysis of four scoring methods and qualitative analysis. Dement. Geriatr. Cogn. Disord. 26 (2008) 483-489
18. Nelson D.A., Tolbert M.D., Singh S.J., and Bost K.L. Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes. J. Neuroimmunol. 192 (2007) 21-30
19. Nishiwaki Y., Breeze E., Smeeth L., Bulpitt C.J., Peters R., and Fletcher A.E. Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly. Am. J. Epidemiol. 160 (2004) 797-807
20. Ravaglia G., Forti P., Maioli F., Chiappelli M., Montesi F., Tumini E., Mariani E., Licastro F., and Patterson C. Blood inflammatory markers and risk of dementia: the Conselice Study of brain aging. Neurobiol. Aging 28 (2007) 1810-1820
21. Revesz T., Ghiso J., Lashley T., Plant G., Rostaqno A., Franqione B., and Holton J.L. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J. Neuropathol. Exp. Neurol. 62 (2003) 885-898
22. Rockwood K., Wentzel C., Hachinski V., Hogan D.B., MacKnight C., and McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the Canadian study on health and aging. Neurology 54 (2000) 447-451
23. Roman G.C., Sachdev P., Royall D.R., Bullock R.A., Orgogozo J.M., López-Pousa S., Arizaga R., and Wallin A. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J. Neurol. Sci. 226 (2004) 81-87
24. Singhal S., Becan S., Barrick T., Rich P., and Markus H.S. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127 (2004) 2031-2038
25. Sisodia S.S., and St Geroge-Hyslop P.H. Gamma-secretase, notch, abeta and Alzheimer's disease: where do the presenilins fit in?. Nat. Rev. Neurosci. 3 (2002) 281-290
26. Tietz N.W. Clinical Guide to Laboratory Tests. 3rd edition (1995), W.B. Saunders Co., Philadelphia p. 1096
27. Turner S.T., Jack C.R., Fornage M., Mosley T.H., Boerwinkle E., and Andarde M. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 43 (2004) 483-487
28. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., Fleisher M., Lilja H., Brogi E., Boyd J., Sanchez-Carbayo M., Holland E.C., Cordon-Cardo C., Scher H.I., and Tempst P. Differential exoproteases activity confer tumor-specific serum peptidome patterns. J. Clin. Invest. 116 (2006) 271-284
29. Wentzel C., Rockwood K., MacKnight C., Hachinski V., Hoqan D.B., Feldman H., Ostbye T., Wolfson C., Gauthier S., Verreault R., and McDowell I. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 57 (2001) 714-716
30. Zhou A.H., and Jia J.P. The value of the clock drawing test and the mini-mental state examination for identifying vascular cognitive impairment no dementia. Int. J. Geriatr. Psychiatry 23 (2008) 422-426
31. Zhou D.H., Wang J.Y., Li J., Deng J., Gao C., and Chen M. Frequency and risk factors of vascular cognitive impairment three months after ischemic stroke in china: the Chongqing stroke study. Neuroepidemiology 24 (2005) 87-95